{"name":"BB Biotech Ventures","permalink":"bb-biotech-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/bb-biotech-ventures","homepage_url":"http://www.bbbiotechventures.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"","description":"","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri Apr 10 16:36:07 UTC 2009","updated_at":"Wed Jun 17 22:25:14 UTC 2009","overview":"<p>BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernseyâ€“based fund is advised by the Bellevue Asset Management Group, which has operations in CuraÃ§ao, Boston/USA and Kusnacht/Zurich, Switzerland. </p>\n\n<p>BB BIOTECH VENTURES has a dedicated team of investment advisors and an advisory board. In addition, it is supported by all of the Groupâ€™s health care investment experts, and an extensive network of specialists and advisors. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, experience, networking, and focus on value creation.</p>","image":{"available_sizes":[[[150,13],"assets/images/resized/0004/9243/49243v1-max-150x150.jpg"],[[250,22],"assets/images/resized/0004/9243/49243v1-max-250x250.jpg"],[[385,35],"assets/images/resized/0004/9243/49243v1-max-450x450.jpg"]],"attribution":null},"offices":[],"relationships":[],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://venturebeat.com/2009/04/08/aerovance-inhales-38m-for-asthma-drugs/","source_description":"Aerovance inhales $38M for asthma drugs","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":7,"company":{"name":"Aerovance","permalink":"aerovance","image":{"available_sizes":[[[150,75],"assets/images/resized/0004/0827/40827v1-max-150x150.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-250x250.png"],[[218,109],"assets/images/resized/0004/0827/40827v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pehub.com/36623/orthocon-raises-25-million/","source_description":"Orthocon Raises $25 Million","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":8,"company":{"name":"Orthocon","permalink":"orthocon","image":{"available_sizes":[[[150,28],"assets/images/resized/0004/0829/40829v1-max-150x150.png"],[[229,44],"assets/images/resized/0004/0829/40829v1-max-250x250.png"],[[229,44],"assets/images/resized/0004/0829/40829v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/palyon-medical-corp-series-a-21m/","source_description":"Palyon Medical Corp.: Series A $21M","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":8,"company":{"name":"Palyon Medical","permalink":"palyon-medical","image":{"available_sizes":[[[150,72],"assets/images/resized/0005/0588/50588v1-max-150x150.jpg"],[[150,72],"assets/images/resized/0005/0588/50588v1-max-250x250.jpg"],[[150,72],"assets/images/resized/0005/0588/50588v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.probiodrug.de/index.php?id=28&tx_ttnews[tt_news]=53&cHash=39e2addbf8","source_description":"Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million)","raised_amount":54000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":2,"company":{"name":"Probiodrug","permalink":"probiodrug","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/4671/64671v1-max-150x150.jpg"],[[198,45],"assets/images/resized/0006/4671/64671v1-max-250x250.jpg"],[[198,45],"assets/images/resized/0006/4671/64671v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020091216e5cg00001&r=Rss&s=DJFVLS","source_description":"Swiss Protein Therapy Co. Molecular Partners Pulls In $44M Series B  ","raised_amount":44200000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":16,"company":{"name":"Molecular Partners","permalink":"molecular-partners","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/0288/70288v1-max-150x150.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-250x250.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://salesandmarketingnetwork.com/news_release.php?pipe=0000ac177000191&ID=2023127","source_description":"BioVascular Inc. Closes $10.87 Million Series C Financing","raised_amount":10870000,"raised_currency_code":"USD","funded_year":2008,"funded_month":2,"funded_day":7,"company":{"name":"BioVascular","permalink":"biovascular","image":{"available_sizes":[[[132,24],"assets/images/resized/0007/0433/70433v1-max-150x150.jpg"],[[132,24],"assets/images/resized/0007/0433/70433v1-max-250x250.jpg"],[[132,24],"assets/images/resized/0007/0433/70433v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.radiuspharm.com/Radius2ndFinancing.pdf","source_description":"Radius Raises $57.5 Million in Second Private Financing Round","raised_amount":57500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":2,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.molecularpartners.com/cnt_press.php?pres=14","source_description":"MOLECULAR PARTNERS SECURES $15.56 million IN SERIES A FINANCING","raised_amount":15560000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":14,"company":{"name":"Molecular Partners","permalink":"molecular-partners","image":{"available_sizes":[[[150,49],"assets/images/resized/0007/0288/70288v1-max-150x150.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-250x250.jpg"],[[185,61],"assets/images/resized/0007/0288/70288v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.tiogapharma.com/press/Tioga%20Feb%202010%20Financing%20PR.pdf","source_description":"Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":17,"company":{"name":"Tioga Pharmaceuticals","permalink":"tioga-pharmaceuticals","image":{"available_sizes":[[[150,58],"assets/images/resized/0007/7570/77570v1-max-150x150.png"],[[250,97],"assets/images/resized/0007/7570/77570v1-max-250x250.png"],[[252,98],"assets/images/resized/0007/7570/77570v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.atlasgenetics.com/press/18_jul_2011.html","source_description":"Atlas Genetics Ltd Completes Â£16.9 million Series B Financing led by Novartis Venture Funds","raised_amount":16900000,"raised_currency_code":"GBP","funded_year":2011,"funded_month":7,"funded_day":18,"company":{"name":"Atlas Genetics","permalink":"atlas-genetics","image":{"available_sizes":[[[150,67],"assets/images/resized/0014/5408/145408v2-max-150x150.jpg"],[[197,89],"assets/images/resized/0014/5408/145408v2-max-250x250.jpg"],[[197,89],"assets/images/resized/0014/5408/145408v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/radius-health-inc-series-c-66m/","source_description":"Radius Health, Inc.: Series C $66M","raised_amount":66000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":26,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.am-pharma.com/press_release20110913_uk.htm","source_description":"AM-Pharma Raises â‚¬29.2m in Series D Financing","raised_amount":29200000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":9,"funded_day":13,"company":{"name":"AM-Pharma","permalink":"am-pharma","image":{"available_sizes":[[[150,32],"assets/images/resized/0015/4065/154065v1-max-150x150.jpg"],[[250,53],"assets/images/resized/0015/4065/154065v1-max-250x250.jpg"],[[450,96],"assets/images/resized/0015/4065/154065v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://radiuspharm.mwnewsroom.com/getattachment/6bc08185-9982-4ca1-8016-ab824b0ed0d7/Radius-Raises-Additional-$15-Million,-Increasing-S","source_description":"Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":11,"funded_day":20,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/01/probiodrug-raises-e15m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Probiodrug Raises €15M in Funding","raised_amount":15000000,"raised_currency_code":"EUR","funded_year":2012,"funded_month":1,"funded_day":4,"company":{"name":"Probiodrug","permalink":"probiodrug","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/4671/64671v1-max-150x150.jpg"],[[198,45],"assets/images/resized/0006/4671/64671v1-max-250x250.jpg"],[[198,45],"assets/images/resized/0006/4671/64671v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/radius-health-inc-series-c-214m/","source_description":"Radius Health, Inc.: Series C $21.4M","raised_amount":21400000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":13,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.tiogapharma.com/press/BioWorldToday1092006.pdf","source_description":"Tiogas Series A Round: $24M For Phase IIb Trial Of IBS Drug","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":9,"company":{"name":"Tioga Pharmaceuticals","permalink":"tioga-pharmaceuticals","image":{"available_sizes":[[[150,58],"assets/images/resized/0007/7570/77570v1-max-150x150.png"],[[250,97],"assets/images/resized/0007/7570/77570v1-max-250x250.png"],[[252,98],"assets/images/resized/0007/7570/77570v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}